Belgium· BE-AMP-SAM589697-00
Fingolimod Mylan 0.5 mg
A fingolimod product containing fingolimod hydrochloride, registered in Belgium by Mylan Pharmaceuticals. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fingolimod is registered in 16 of 19 countries.
Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Fingolimod · ATC L04AE01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fingolimod costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fingolimod · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- IT Italy$27.25
- CH Switzerland$18.53
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fingolimod Hydrochloride
- Manufacturer
- Mylan Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L04AE01
- ATC class
- Fingolimod
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7733272
- be_apb4407664
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
584 interactions on record for fingolimod.
Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fingolimod · interactions on record
584 records
- 503 severe
- 77 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fingolimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARELEPTANPharmaselect International Beteiligungs GmbH, Vídeň
- SpainFINGOLIMOD ACCORD 0,5 mg CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- PolandAreleptanPharmaselect International Beteiligungs GmbH
- NetherlandsChantico 0,5 mg harde capsulesG.L. Pharma GmbH
- United StatesfingolimodGlenmark Pharmaceuticals Inc., USA
- FinlandAreleptanPharmaselect International Beteiligungs GmbH
- SwedenAreleptan 0,5 mg Kapsel, hårdPharmaselect International Beteiligungs GmbH
- United KingdomFingolimod 500microgram capsulesAlliance Healthcare (Distribution) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areleptan, Chantico
- Bulgaria · Chantico, Inzolfi
- Cyprus · Fingolimod Adelco, Fingolimod Remedica
- Czechia · Areleptan, Bonaxon
- Germany · Fingod, Fingolimod 123 Acurae Pharma
- Denmark · Areleptan, Bonaxon
- Estonia · Chantico, Efigalo
- Spain · Fingolimod, Fingolimod Aurovitas
- Finland · Fingolimod, Fingolimod Avansor
- France · Fingolimod Arrow, Fingolimod Benta
- United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
- Greece · Fingolimod Adelco, Fingolimod Medochemie
- Croatia · Areleptan, Arlesias
- Hungary · Bonaxon, Chantico
- Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
- Iceland · Fingolimod, Fingolimod Accord
- Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
- Liechtenstein · Fingolimod Accord, Fingolimod Mylan
- Lithuania · Chantico, Efigalo
- Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
- Latvia · Bonaxon, Chantico
- Malta · Fingolimod Denk, Fingolimod Remedica
- Netherlands · Chantico, Fenoxa
- Norway · Areleptan, Fingolimod Accord
- Poland · Bonaxon, Chantico
- Portugal · Bluesar, Fingolimod Bluefish
- Romania · Fingolimod Dr. Reddys, Fingolimod Msn
- Sweden · Areleptan, Fingolimod Amarox
- Slovenia · Areleptan, Arlesias
- Slovakia · Areleptan, Bonaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be2bee2b-0041-437b-bafb-aa87303882b5 GET /v1/drugs/be2bee2b-0041-437b-bafb-aa87303882b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Fingolimod Mylan 0.5 mg",
"name_fr": "Fingolimod Mylan 0.5 mg",
"name_nl": "Fingolimod Mylan 0.5 mg",
"amp_code": "SAM589697-00",
"strengths": [
"0.5000",
"0.5000"
],
"pack_count": 24,
"substances": [
"Fingolimod Hydrochloride",
"Fingolimod",
"Potassium Hydroxide",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fingolimod",
"authorisation_numbers": [
"EU/1/21/1573/003",
"EU/1/21/1573/004",
"EU/1/21/1573/001",
"EU/1/21/1573/002",
"EU/1/21/1573/007",
"EU/1/21/1573/008",
"EU/1/21/1573/005",
"EU/1/21/1573/006",
"EU/1/21/1573/011",
"EU/1/21/1573/012",
"EU/1/21/1573/009",
"EU/1/21/1573/010",
"EU/1/21/1573/015",
"EU/1/21/1573/016",
"EU/1/21/1573/013",
"EU/1/21/1573/014",
"EU/1/21/1573/019",
"EU/1/21/1573/020",
"EU/1/21/1573/017",
"EU/1/21/1573/018",
"EU/1/21/1573/023",
"EU/1/21/1573/024",
"EU/1/21/1573/021",
"EU/1/21/1573/022"
]
}See everything about fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.